NMPA Approval

Inebilizumab Injection

Approval Number

国药准字SJ20220007

Registration Date

March 8, 2022

Drug Information

Generic Name

伊奈利珠单抗注射液

Trade Name

昕越

Dosage Form

注射剂

Strength

100mg（10mL）/小瓶

Drug Type

生物制品

Registration Date

March 8, 2022

Expiry Date

March 7, 2027

Company Address

70 St. Stephen's Green, Dublin 2, Dublin D02 E2X4 IRELAND

Company Address

Lagelandseweg 78, Nijmegen, 6545CG Netherlands

Empowering clinical research with data-driven insights and AI-powered tools.